Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
暂无分享,去创建一个
S. Honsawek | Y. Poovorawan | N. Wanlapakorn | R. Yorsaeng | J. Chansaenroj | S. Klinfueng | T. Thongmee | N. Sudhinaraset | D. Srimuan | N. Suntronwong | P. Vichaiwattana | P. Nilyanimit | S. Assawakosri | S. Kanokudom | T. Thatsanatorn | R. Aeemjinda | N. Khanarat | Apirat Katanyutanon | Wichai Thanasopon | Jirawan Arayapong | Withak Withaksabut